PreveCeutical Medical Inc. (CSE: PREV)
Canada
· Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Nov 21, 2024, 11:09 AM EST
PreveCeutical Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | - | - | - | - | - | 0 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -80.38% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 0 | Upgrade
|
| Gross Profit | - | - | - | - | - | 0 | Upgrade
|
| Selling, General & Admin | 0.72 | 0.68 | 0.57 | 0.68 | 0.64 | 1.16 | Upgrade
|
| Research & Development | 0.09 | 0.09 | 0.08 | 0.06 | 0.21 | 1.67 | Upgrade
|
| Operating Expenses | 0.87 | 0.92 | 1.04 | 0.83 | 2.09 | 3.44 | Upgrade
|
| Operating Income | -0.87 | -0.92 | -1.04 | -0.83 | -2.09 | -3.44 | Upgrade
|
| Interest Expense | -0.32 | -0.31 | -0.24 | -0.47 | -0.64 | -0.58 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0 | -0 | -0.21 | 0.12 | -0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.05 | -0.06 | -0.06 | 0.1 | 0.58 | Upgrade
|
| EBT Excluding Unusual Items | -1.26 | -1.27 | -1.34 | -1.58 | -2.51 | -3.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0 | -0 | -0.08 | - | Upgrade
|
| Other Unusual Items | - | - | -0.15 | -0.17 | -1.22 | - | Upgrade
|
| Pretax Income | -1.26 | -1.27 | -1.48 | -1.75 | -3.81 | -3.59 | Upgrade
|
| Income Tax Expense | - | - | - | -0.02 | -0.01 | -0.01 | Upgrade
|
| Net Income | -1.26 | -1.27 | -1.48 | -1.73 | -3.8 | -3.58 | Upgrade
|
| Net Income to Common | -1.26 | -1.27 | -1.48 | -1.73 | -3.8 | -3.58 | Upgrade
|
| Shares Outstanding (Basic) | 536 | 535 | 522 | 508 | 456 | 396 | Upgrade
|
| Shares Outstanding (Diluted) | 536 | 535 | 522 | 508 | 456 | 396 | Upgrade
|
| Shares Change (YoY) | 0.96% | 2.59% | 2.72% | 11.43% | 15.19% | 24.10% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | Upgrade
|
| Free Cash Flow | -0.34 | -0.3 | -0.22 | -0.43 | 0.06 | -0.99 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| Gross Margin | - | - | - | - | - | 74.30% | Upgrade
|
| Operating Margin | - | - | - | - | - | -113356.09% | Upgrade
|
| Profit Margin | - | - | - | - | - | -118076.54% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -32792.35% | Upgrade
|
| EBITDA | -0.86 | -0.91 | -1.03 | -0.83 | -2.08 | -3.41 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
| EBIT | -0.87 | -0.92 | -1.04 | -0.83 | -2.09 | -3.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.